An allergic skin reaction to a new formulation of the molluscicide clonitralide (Bayluscide).
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003140:Communicable Disease Control; D004342:Drug Hypersensitivity; D004781:Environmental Exposure; D004983:Ethanolamines / Q000009:adverse effects; D006801:Humans; D006854:Hydrocortisone; D008297:Male; D008975:Molluscacides / Q000009:adverse effects*; D009534:Niclosamide / Q000009:adverse effects*; D011537:Pruritus / Q000139:chemically induced / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D004983:Ethanolamines; D008975:Molluscacides; D009534:Niclosamide; D006854:Hydrocortisone